tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephen Willey, 165 are a BUY (71.43%), 64 are a HOLD (27.71%), 2 are a SELL (0.87%).
Analyst Stephen Willey, currently employed at STIFEL, carries an average stock price target met ratio of 48.35% that have a potential upside of 31.53% achieved within 178 days.
Stephen Willey’s has documented 417 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 09-Apr-2025.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
2 years 11 months 11 days ago
(17-May-2022)
3/4 (75%)
$-0.12 (-1.96%)
12
Hold
$5
$1.52 (43.68%)
$9
2 years 11 months 15 days ago
(13-May-2022)
1/3 (33.33%)
$2.28 (83.82%)
2
Hold
3 years 4 months 1 days ago
(28-Dec-2021)
0/1 (0%)
$26.16 (77.30%)
Buy
$40
3 years 4 months 13 days ago
(16-Dec-2021)
1/1 (100%)
$6.16 (18.20%)
3
Which stock is Stephen Willey is most bullish on?
Which stock is Stephen Willey is most reserved on?
What Year was the first public recommendation made by Stephen Willey?
